CMC

R&D

Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.

Events

Partner Content

Overcome comparability challenges in gene therapy!

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.